NeoDynamics Investor Relations Material
Latest events
Q1 2024
7 May, 2024
Q4 2023
16 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeoDynamics
Access all reports
NeoDynamics AB is a Swedish medical technology company focused on advancing cancer diagnosis and treatment. The company's flagship product, NeoNavia, is an innovative biopsy system designed for precise, ultrasound-guided tissue sampling. Built on patented pulse technology, NeoNavia enables controlled needle insertion and accurate placement within tumors, particularly for diagnosing breast cancer and axillary lymph nodes. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
NEOD
Country
🇸🇪 Sweden